Inhibitory Effects of Salvianolic Acid B on the High Glucose-Induced Mesangial Proliferation via NF-.KAPPA.B-Dependent Pathway
Authors:
- 1 January 2008
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 31 (7) , 1381-1386
Abstract
Salvianolic acid B (Sal B) is one of the major water-soluble compounds isolated from Radix Salviae Miltiorrhizae (Danshen in Chinese) that has been reported to be beneficial to treatment of diabetic complications. However, the mechanisms involved in these effects are not discussed in relation to mesangial proliferation via modulation of NF-kappaB. To explain this, human mesangial cells were pretreated with or without Sal B (0.1, 1, 10 microM) for 24 h and stimulated with high glucose (30 mM). Then the effects of Sal B on mesangial cells proliferation, extracellular matrix production and the possible mechanisms were evaluated by methylthiazoletetrazolium assay, flow cytometry assay, enzyme-linked immunosorbent assay, gelatin zymography assay and western blot assay. These results indicated that Sal B could inhibit high glucose-induced mesangial cells proliferation and extracellular matrix production in a dose-dependent manner, partially through modulating the cell-cycle progress and MMP-2 and MMP-9 activities via suppressing NF-kappaB activation, suggesting that Sal B may be a promising agent for treating diabetic nephropathy.Keywords
This publication has 36 references indexed in Scilit:
- Angiotensin II Receptor Blockade Ameliorates Mesangioproliferative Glomerulonephritis in Rats through Suppression of CTGF and PAI-1, Independently of the Coagulation SystemNephron Experimental Nephrology, 2006
- Downregulation of Connexin 43 Expression by High Glucose Induces Senescence in Glomerular Mesangial CellsJournal of the American Society of Nephrology, 2006
- Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanismJournal of Chinese Integrative Medicine, 2005
- Peroxynitrite scavenging activity of lithospermate B from Salvia miltiorrhizaJournal of Pharmacy and Pharmacology, 2003
- Delayed Treatment with Lithospermate B Attenuates Experimental Diabetic Renal InjuryJournal of the American Society of Nephrology, 2003
- Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular diseaseMedicinal Research Reviews, 2002
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Magnesium Lithospermate B Suppresses the Increase of Active Oxygen in Rats after Subtotal NephrectomyNephron, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Animal Cell Cycles and Their ControlAnnual Review of Biochemistry, 1992